Literature DB >> 28260272

Lisfranc injuries.

Sacha Wynter, Cameron Grigg.   

Abstract

BACKGROUND: Injury to the tarsometatarsal joint is a relatively rare occurrence that is commonly missed, leading to debilitating outcomes. For this reason, it is considered a red flag in general practice.
OBJECTIVE: This article reviews the current literature on tarsometatarsal injuries and describes clinical assessment, imaging and management. DISCUSSION: Lisfranc injuries refer to the displacement of the metatarsals from the tarsus, with special attention placed on the second tarsometa-tarsal joint and Lisfranc ligament. These injuries can occur in numerous circumstances, such as motor vehicle accidents, crush inju-ries and falls. Indirect mechanisms include axial force through the foot or twisting on a plantar flexed foot. Suggestive examination signs include plantar ecchymosis, mid-foot pain and positive findings in the provocative tests described in the article. Weight-bearing radiographs are vital for diagnosis. Correct and prompt management is key to avoiding posttraumatic arthritis, a devastating but common complication of Lisfranc injuries.

Entities:  

Mesh:

Year:  2017        PMID: 28260272

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

Review 1.  [Injuries of ligaments and tendons of foot and ankle : What every radiologist should know].

Authors:  K M Thierfelder; I N Gemescu; M-A Weber; R Meier
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

2.  Reliability of various diastasis measurement methods on weightbearing radiographs in patients with subtle Lisfranc injuries.

Authors:  Yuki Sugino; Ichiro Yoshimura; Tomonobu Hagio; Tetsuro Ishimatsu; Masaya Nagatomo; Takuaki Yamamoto
Journal:  Skeletal Radiol       Date:  2021-08-19       Impact factor: 2.199

3.  Irreducible Lisfranc injury by tibialis anterior tendon entrapment: A case report.

Authors:  Do-Yeon Kim; Jong-Kil Kim; Min-Woo Kim; Kwang Bok Lee
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.